Although they constitute <2% of all incident cancers, melanoma is the fifth most lethal due to an intrinsic resistance to standard chemotherapy [1], radiation therapy [2], targeted therapies such as BRAF inhibitors [3,4], and immunotherapy such as immune checkpoint inhibitors (ICI) [5]. This evidence concerns the gene BRAF and melanoma.